PREFORMED LINE VP exercises options, returns 1,000 shares

PREFORMED LINE PRODUCTS CO executive Assaad A. Morcos, VP US Manufacturing, reported option-related transactions and equity awards.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PREFORMED LINE PRODUCTS CO executive Assaad A. Morcos, VP US Manufacturing, reported option-related transactions and equity awards. He exercised 1,000 common shares through employee stock options at $132.40 per share and then disposed of 1,000 common shares back to the issuer at $360.91 per share, leaving no directly held common shares from this exercise.

Following these transactions, he directly holds 3,750 employee stock options and restricted stock units covering 407 and 681 underlying common shares, which vest three years from the grant date. A prior grant on December 11, 2024 totaled 7,500 options with staged vesting through 2027.

Insider Trade Summary

1,000 shares exercised/converted

Exercise 5 txns

Insider Morcos Assaad A

Role VP, US Manufacturing

Type	Security	Shares	Price	Value
Exercise	Employee stock option (right to buy)	1,000	$132.40	$132K
Exercise	Common Shares, $2 par value per share	1,000	$132.40	$132K
Disposition	Common Shares, $2 par value per share	1,000	$360.91	$361K
holding	Restricted stock units	--	--	--
holding	Restricted stock units	--	--	--

Holdings After Transaction: Employee stock option (right to buy) — 3,750 contracts (Direct); Common Shares, $2 par value per share — 0 shares (Direct); Restricted stock units — 1,088 contracts (Direct)

Footnotes (2)

F1. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.
F2. Restricted stock units vest 3 years from the date of grant.

Key Figures

Shares exercised: 1,000 shares Exercise price: $132.40 per share Disposition price to issuer: $360.91 per share +4 more

7 metrics

Shares exercised 1,000 shares Employee stock option exercise on 2026-06-10

Exercise price $132.40 per share Employee stock option (right to buy) conversion

Disposition price to issuer $360.91 per share 1,000 common shares disposed to issuer on 2026-06-10

Options remaining 3,750 options Employee stock option position following transaction

Original option grant 7,500 options Granted on December 11, 2024 with staged vesting

RSU underlying shares 407 shares Restricted stock units with 3-year vesting

Additional RSU underlying shares 681 shares Restricted stock units with 3-year vesting

Key Terms

Restricted stock units, Employee stock option, Disposition to issuer, Vesting

4 terms

Restricted stock units financial

"Restricted stock units vest 3 years from the date of grant."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employee stock option financial

"Employee stock option (right to buy) with a $132.4000 price."

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

Disposition to issuer financial

"Transaction code D is described as Disposition to issuer."

Vesting financial

"3,750 vested on December 11, 2025; later tranches will vest in 2026 and 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Assaad A. Morcos report in this PLPC Form 4 filing?

Assaad A. Morcos reported an option exercise and related share disposition. He exercised 1,000 employee stock options, acquired 1,000 common shares, then disposed of 1,000 shares back to PREFORMED LINE PRODUCTS CO, plus updated his remaining option and RSU holdings.

How many PREFORMED LINE PRODUCTS CO shares did Morcos exercise and at what price?

He exercised stock options for 1,000 common shares at $132.40 per share. These options were part of a 7,500-option grant awarded on December 11, 2024, with portions vesting in 2025, 2026, and 2027 under the company’s equity compensation plan.

What was the disposition of PREFORMED LINE PRODUCTS CO shares in this Form 4?

The filing shows a disposition of 1,000 common shares to the issuer at $360.91 per share, coded as a disposition to issuer. This is not classified as an open-market sale but as shares returned directly to PREFORMED LINE PRODUCTS CO.

What PREFORMED LINE PRODUCTS CO equity awards does Morcos hold after the transactions?

After the transactions, Morcos holds 3,750 employee stock options and restricted stock units linked to 407 and 681 underlying common shares. These RSUs vest three years from their respective grant dates, providing future share delivery if vesting conditions are met.

What is the vesting schedule of Morcos’s PREFORMED LINE PRODUCTS CO stock options?

On December 11, 2024, he was granted 7,500 stock options. Of these, 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027, with a ten-year expiration.

How are Morcos’s restricted stock units in PREFORMED LINE PRODUCTS CO structured?

The filing states that his restricted stock units vest three years from the date of grant. Two RSU positions correspond to 407 and 681 underlying common shares, providing future share delivery once the three-year vesting period is satisfied for each grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/10/2026 - 12:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morcos Assaad A

(Last)

(First)

(Middle)

660 BETA DRIVE

(Street)

CLEVELAND

OHIO

44143

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PREFORMED LINE PRODUCTS CO [ PLPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, US Manufacturing

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares, $2 par value per share	06/10/2026	06/10/2026	M		1,000⁽¹⁾	A	$132.4	1,000	D
Common Shares, $2 par value per share	06/10/2026		D		1,000	D	$360.91	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee stock option (right to buy)	$132.4	06/10/2026	06/10/2026	M			1,000	⁽¹⁾	⁽¹⁾	Common Shares, $2 par value per share	1,000	$132.4	3,750	D
Restricted stock units	$0							⁽²⁾	⁽²⁾	Common shares, $2 par value	681		681	D
Restricted stock units	$0							⁽²⁾	⁽²⁾	Common shares, $2 par value	407		407	D

Explanation of Responses:

1. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

2. Restricted stock units vest 3 years from the date of grant.

Remarks:

	/s/ Caroline S Vaccariello, by power of attorney	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR